Alembic Pharmaceuticals submits copy of press release

05 Dec 2016 Evaluate

Alembic Pharmaceuticals has submitted a copy of Press Release dated December 05, 2016 titled ‘Alembic Pharmaceuticals receives USFDA Approval for Zolmitriptan Orally Disintegrating Tablets.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

852.30 -4.95 (-0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×